Creekmur Asset Management LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 187.4% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,153 shares of the healthcare conglomerate's stock after buying an additional 1,404 shares during the quarter. Creekmur Asset Management LLC's holdings in UnitedHealth Group were worth $1,128,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also recently modified their holdings of the company. Financial Management Professionals Inc. lifted its position in shares of UnitedHealth Group by 0.8% during the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock worth $1,165,000 after buying an additional 17 shares in the last quarter. Richwood Investment Advisors LLC grew its stake in UnitedHealth Group by 0.4% in the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock valued at $2,654,000 after buying an additional 20 shares in the last quarter. Global Wealth Strategies & Associates grew its stake in UnitedHealth Group by 28.6% in the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock valued at $47,000 after buying an additional 20 shares in the last quarter. Kolinsky Wealth Management LLC grew its stake in UnitedHealth Group by 1.0% in the 4th quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock valued at $1,080,000 after buying an additional 21 shares in the last quarter. Finally, Retirement Planning Group LLC grew its stake in UnitedHealth Group by 5.1% in the 1st quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock valued at $225,000 after buying an additional 21 shares in the last quarter. Institutional investors own 87.86% of the company's stock.
Insiders Place Their Bets
In other news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares in the company, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Stephen J. Hemsley bought 86,700 shares of the stock in a transaction dated Friday, May 16th. The stock was purchased at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the acquisition, the chief executive officer directly owned 679,493 shares in the company, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders bought 109,408 shares of company stock worth $31,607,768. Insiders own 0.28% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research analysts have recently commented on the stock. Truist Financial reduced their price target on shares of UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating for the company in a research report on Wednesday. Raymond James Financial lowered shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday, May 14th. KeyCorp reduced their price target on shares of UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating for the company in a research report on Monday, June 2nd. Robert W. Baird lowered shares of UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 target price for the company. in a research report on Wednesday, June 11th. Finally, Wolfe Research cut their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research report on Tuesday, May 20th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of "Moderate Buy" and an average target price of $394.43.
Get Our Latest Research Report on UnitedHealth Group
UnitedHealth Group Stock Down 0.5%
Shares of UnitedHealth Group stock opened at $286.72 on Friday. The company has a market cap of $260.10 billion, a price-to-earnings ratio of 12.05, a price-to-earnings-growth ratio of 1.42 and a beta of 0.45. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The company's 50 day moving average is $306.43 and its 200 day moving average is $434.93. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter in the previous year, the business earned $6.91 earnings per share. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were paid a $2.21 dividend. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.08%. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report